Gene therapy using HVJ-liposomes: the best of both worlds? (Q33666050)

28 July 2017

1 reference

title

Gene therapy using HVJ-liposomes: the best of both worlds? (English)

1 reference

28 July 2017

0 references

Kaneda Y

1

1 reference

28 July 2017

Saeki Y

series ordinal

2

1 reference

28 July 2017

Morishita R

series ordinal

3

1 reference

28 July 2017

publication date

1 July 1999

1 reference

Trends in Molecular Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

7

1 reference

28 July 2017

page(s)

298-303

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

28 July 2017

1 reference

7 January 2021

The basic science of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Nonviral gene therapy: the promise of genes as pharmaceutical products

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Pseudotyped retroviral vectors for studies of human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Sendai virus-induced cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Increased expression of DNA cointroduced with nuclear protein in adult rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

The potential of extrachromosomal replicating vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Fusigenic viral liposome for gene therapy in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901482-3

7 January 2021

10.1016/S1357-4310(99)01482-3

Identifiers

DOI

1 reference

28 July 2017

1 reference